All Stories

  1. Response to Letter to the Editor: Decreased Risk of Mental Illness Worsening: Comment on “Glucagon-like Peptide-1 Receptor Agonists in Individuals With Severe Mental Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
  2. Celecoxib adjunct to antidepressants for major depressive disorder: Systematic review and meta-analysis
  3. Depressive symptom profiles across pregnant, postpartum, and nonperipartum women: measurement invariance and differential item functioning analyses of 2005–2021 NHANES data
  4. Glucagon-Like Peptide-1 Receptor Agonists in Individuals With Severe Mental Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  5. Diagnostic and clinical utility of exome sequencing and chromosomal microarray in children with GDD/iD: a meta-analysis
  6. Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: A systematic review and meta- analysis
  7. Second-generation antipsychotics for Parkinson's disease psychosis: A systematic review and network meta-analysis
  8. Efficacy and acceptability of vitamin D supplements for depressed patients: A systematic review and meta-analysis of randomized controlled trials
  9. Aortic Peak Flow Velocity As a Predictor of Fluid Responsiveness in Mechanically Ventilated Children: A Systematic Review and Meta-Analysis
  10. Convergent Validity of the Edinburgh Postnatal Depression Scale and the Patient Health Questionnaire (PHQ-9) in Pregnant and Postpartum Women: Their Construct Correlations with Functional Disability
  11. Serum oxytocin and corticotropin-releasing hormone levels in the third trimester of pregnancy for predicting postpartum depression in Thai women
  12. Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials
  13. Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
  14. Antidepressants for depressed patients with type 2 diabetes mellitus: A systematic review and network meta-analysis of short-term randomized controlled trials
  15. The bidirectional relationship between obesity and executive function in children and adolescents
  16. Course and predictors of disability in Thai patients with schizophrenia: A 2-year, multi-center, prospective, observational study
  17. The Effects of Neurofeedback on Executive Functioning in Children With ADHD: A Meta-Analysis
  18. Thai Medical and Nursing Students: COVID-19 Fear Associated with Mental Health and Substance Use
  19. Cross national comparison of medical students’ attitudes and beliefs about medical cannabis and its application for pain management
  20. A meta-analysis comparing short-term weight and cardiometabolic changes between olanzapine/samidorphan and olanzapine
  21. A network meta-analysis of the dose–response effects of lurasidone on acute schizophrenia
  22. Blue-wavelength light therapy for post-traumatic brain injury sleepiness, sleep disturbance, depression, and fatigue: A systematic review and network meta-analysis
  23. Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis
  24. Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation for prevention and treatment of perinatal depression: a systematic review and meta-analysis of randomized-controlled trials
  25. The Effect of Mindfulness-Based Intervention on Brain-Derived Neurotrophic Factor (BDNF): A Systematic Review and Meta-Analysis of Controlled Trials
  26. Development and implementation of guidelines for the management of depression: a systematic review
  27. Blue-wavelength Light Therapy for Post-traumatic Brain Injury Sleepiness, Sleep Disturbance, Depression, Fatigue: A Systematic Review and Network Meta-analysis
  28. Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand
  29. Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials
  30. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand
  31. Subjective depressive symptoms associated with pain in patients with major depressive disorder: Findings from the study on the aspect of Asian depression
  32. Perception of Stigma and Its Associated Factors Among Patients With Major Depressive Disorder: A Multicenter Survey From an Asian Population
  33. Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
  34. Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
  35. Risperidone for children and adolescents with autism spectrum disorder: a systematic review
  36. Cognitive complaints and predictors of perceived cognitive dysfunction in adults with major depressive disorder: Findings from the Cognitive Dysfunction in Asians with Depression (CogDAD) study
  37. Polydrug use among kratom users: Findings from the 2011 Thailand National Household Survey
  38. Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study
  39. Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study
  40. Depression in Kidney Transplant Recipients
  41. Internal consistency and concurrent validity of the Montreal Cognitive Assessment in individuals with major depressive disorder
  42. Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder
  43. Discrepancy between objective and subjective cognition in adults with major depressive disorder
  44. Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
  45. Delirium after a traumatic brain injury: predictors and symptom patterns
  46. Gender Differences in Depressive Symptoms in Thai Individuals with Depressed Mood and/or Anhedonia: A Differential Item Functioning Approach
  47. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials
  48. Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials
  49. Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, Asian outpatients with major depressive disorder
  50. Correlates of health-related quality of life in Thai patients with alcohol dependence
  51. Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?
  52. Routledge Handbook of Psychiatry in Asia
  53. The association of suicide risk with negative life events and social support according to gender in Asian patients with major depressive disorder
  54. Correlates of Disability in Asian Patients With Major Depressive Disorder
  55. Stressful life events preceding the onset of depression in Asian patients with major depressive disorder
  56. Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials
  57. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: A systematic review and meta-analysis of randomized-controlled trials
  58. Is Early-onset in Major Depression a Predictor of Specific Clinical Features with More Impaired Social Function?
  59. Subjective memory and concentration deficits in medication-free, non-elderly Asians with major depressive disorder: Prevalence and their correlates
  60. Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
  61. P.1.g.011 A systematic review of randomised controlled trials of lisdexamfetamine versus placebo in the treatment of adults with ADHD
  62. Relaxation for perimenopausal and postmenopausal symptoms
  63. Quetiapine for acute bipolar depression: a systematic review and meta-analysis
  64. Risk factors for an anxiety disorder comorbidity among Thai patients with bipolar disorder: results from the Thai Bipolar Disorder Registry
  65. Treatment for amphetamine dependence and abuse
  66. Suicide risk among Thai illicit drug users with and without mental/alcohol use disorders
  67. Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
  68. EPA-0239 – Quetiapine for acute bipolar depression: a systematic review and meta-analysis
  69. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: A 12-week, randomized, placebo-controlled trial
  70. Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry
  71. Effectiveness of a modified version of the applied relaxation technique in treatment of perimenopausal and postmenopausal symptoms
  72. Differences in psychiatric symptoms among Asian patients with depression: A multi-country cross-sectional study
  73. Modified relaxation technique for treating hypertension in Thai postmenopausal women
  74. Clinical features of depression in Asia: Results of a large prospective, cross-sectional study
  75. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized–controlled trials comparison with venlafaxine
  76. Time to relapse and remission of bipolar disorder: findings from a 1-year prospective study in Thailand
  77. Prevalence and predictors of pain in patients with major depressive disorder
  78. Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial
  79. Melancholic features and hostility are associated with suicidality risk in Asian patients with major depressive disorder
  80. Quetiapine versus typical antipsychotic medications for schizophrenia
  81. Addiction potential of phentermine prescribed during long-term treatment of obesity
  82. Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia
  83. 1564 – Reliability and validity of the thai version of the calgary depression scale for schizophrenia
  84. 462 – Quetiapine monotherapy in acute phase for major depressive disorder: a metaanalysis of randomized, placebo-controlled trials
  85. Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: Findings from the 2008 Thai National Mental Health survey
  86. P.6.a.007 Topiramate for alcoholism in patients recently receiving inpatient detoxification: a 12-week, randomised, placebo-controlled trial
  87. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials
  88. Cognitive changes in topiramate-treated patients with alcoholism: A 12-week prospective study in patients recently detoxified
  89. Patterns of alcohol dependence in Thai drinkers: A differential item functioning analysis of gender and age bias
  90. Bupropion for adults with attention-deficit hyperactivity disorder: Meta-analysis of randomized, placebo-controlled trials
  91. P.5.e.002 A double-blind, randomised, controlled trial of quetiapine versus haloperidol for the treatment of delirium: a preliminary report
  92. P.3.a.005 Prevalence of pain and its correlation to depression: a cross-section study in major depressive patients
  93. P.6.a.004 Endorsement patterns of DSM-IV alcohol dependence criteria in Thai women and adolescents: a differential item functioning approach
  94. S28-01 The Clinical Features of Depression in Asia: Results of a Large, Prospective, Cross-Sectional Study
  95. Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: A 12-week, randomized, controlled trial
  96. Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis
  97. Opioid antagonists for alcohol dependence
  98. Treatment for inhalant dependence and abuse
  99. Methamphetamine Psychosis in Australia, Philippines, and Thailand
  100. Relaxation for perimenopausal and postmenopausal symptoms
  101. Quetiapine versus other atypical antipsychotics for schizophrenia
  102. Quetiapine versus typical antipsychotic medications for schizophrenia
  103. Treatment for inhalant dependence and abuse
  104. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual
  105. Psychometric evaluation of the Amphetamine Cessation Symptom Assessment
  106. Quetiapine versus other atypical antipsychotics for schizophrenia
  107. The treatment of alcohol dependence
  108. Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
  109. Interventions to reduce benzodiazepine prescribing
  110. Brief Intervention for Students with Methamphetamine Use Disorders: A Randomized Controlled Trial
  111. P.5.e.002 An open-label study of quetiapine for delirium
  112. P.6.a.007 Risks and pattern of alcohol withdrawal delirium
  113. P.6.c.001 Benzodiazepines misuse in outpatients treated by internists
  114. The nature, time course and severity of methamphetamine withdrawal
  115. Benzodiazepine prescribing behaviour and attitudes: a survey among general practitioners practicing in northern Thailand
  116. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials
  117. Opioid antagonists for alcohol dependence
  118. Interventions to reduce benzodiazepine prescribing
  119. Quetiapine for schizophrenia
  120. Psychotic symptoms in methamphetamine psychotic in-patients
  121. A factor structure of methamphetamine psychotic symptoms
  122. Opioid antagonists for alcohol dependence
  123. Impact on Thai Psychiatrists of Passive Dissemination of a Clinical Practice Guideline on Prescribing Attitudes in Treatment-Resistant Schizophrenia
  124. Treatment for amphetamine withdrawal
  125. Treatment for amphetamine dependence and abuse
  126. Treatment for amphetamine psychosis
  127. HIV-Seropositive Results, Health-Related Quality of Life, and Social Support: A 24-Week Prospective Study in Thailand
  128. A factor analysis of amphetamine psychotic symptoms: Preliminary results
  129. Does the Addition of Pindolol Accelerate the Response to Electroconvulsive Therapy in Patients with Major Depression? A Double-Blind, Placebo-Controlled Pilot Study
  130. Quetiapine for schizophrenia
  131. Evaluation of three simple methods for predicting therapeutic lithium doses
  132. Seasonal variations in mood and behaviour: epidemiological findings in the north tropics
  133. Amphetamine Withdrawal: I. Reliability, Validity and Factor Structure of a Measure
  134. Amphetamine Withdrawal: II. A Placebo-Controlled, Randomised, Double-Blind Study of Amineptine Treatment
  135. Amitriptyline vs. lorazepam in the treatment of opiate-withdrawal insomnia: a randomized double-blind study
  136. COMPARATIVE STUDIES OF THE BIOLOGICAL DISTINCTION BETWEEN UNIPOLAR AND BIPOLAR DEPRESSIONS
  137. Effect of Stimulus Intensity on Prolactin and Cortisol Release Induced by Unilateral Electroconvulsive Therapy
  138. Role of serotonin3 receptors in prolactin release induced by electroconvulsive therapy: A study with ondansetron
  139. Treatment of Acute Bipolar Depression: A Review of the Literature